Evan M Chen Selected Research

4-dioxanone

1/2018

Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evan M Chen Research Topics

Disease

2	Infections 10/2022 - 01/2022
2	COVID-19 10/2022 - 01/2022
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2018 - 01/2017
1	Uveitis 10/2022
1	Macular Edema 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Glioma (Gliomas) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Diffuse Intrinsic Pontine Glioma 01/2017
1	Disease Progression 01/2017

Drug/Important Bio-Agent (IBA)

2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	4-dioxanoneIBA 01/2018
1	poly(omega- pentadecalactone- co- p- dioxanone)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	dipinacoline glutamateIBA 01/2017

Therapy/Procedure

2	Light Coagulation 01/2021 - 01/2021
2	Radiotherapy 01/2018 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Combined Modality Therapy 01/2017